18
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Comparison of Total and IgG ABO Antibody Titers in Healthy Individuals by Using Tube and Column Agglutination Techniques

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Most immune reactions related to transfusion and transplantation are caused by IgM ABO antibodies. However, IgG also plays an important role in these reactions. Therefore, a method to measure antibodies, including IgG, is necessary. We investigated ABO antibody titers of healthy individuals using a column agglutination technique (CAT) with or without dithiothreitol (DTT) and compared them with titers obtained using a conventional tube method.

          Methods

          Among healthy adults who underwent a medical examination, 180 individuals (60 with blood group A, 60 with group B, and 60 with group O) were selected. Antibody titrations were performed using the immediate spin (IS) tube, anti-human globulin (AHG) tube, and CAT with or without DTT methods.

          Results

          Higher median values of anti-B and anti-A titers in groups A and B individuals, respectively, were obtained using the IS method than using the AHG method. Higher values for group O individuals were obtained using the AHG method. Higher median titers of anti-B and anti-A in group O individuals were obtained using CAT without DTT than using the AHG method. Median titers of anti-B and anti-A in all blood groups were higher in CAT without DTT than in CAT with DTT, especially for group O individuals.

          Conclusions

          We recommend CAT with and without DTT for titration of anti-A and anti-B, especially in group O individuals, to provide more sensitive results that include IgG data. Adjustment of insurance coverage of fees associated with antibody titration might be necessary, considering the actual cost of reagents and personnel.

          Related collections

          Most cited references21

          • Record: found
          • Abstract: found
          • Article: not found

          Role of anti-A/B antibody titers in results of ABO-incompatible kidney transplantation.

          Our previous studies showed that the incidence of humoral rejection was extremely high in ABO-incompatible living kidney transplantation. This result suggests that anti-A/B antibody titers directly influence the graft survival of ABO-incompatible kidney transplantation. In this study, we examined the impact of preoperative anti-A/B antibody titers on the results of ABO-incompatible living kidney transplantation.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            A series of surveys on assay for anti-A/B antibody by Japanese ABO-incompatible Transplantation Committee.

            The measurement of anti-blood groups A and B antibody (Ab) titers is considered to be important in ABO-incompatible transplantation. However, no standard method for quantitative determination has yet been established in Japan. Inter-examiner variability was likely because Ab titer was determined mainly by visual observation. In order to assess inter-institutional variation in the measurement of anti-A/B Ab titer, a series of surveys was conducted by the Japanese ABO-incompatible Transplantation Committee. In 2003, the first national survey was conducted. Serum samples from six healthy volunteers with blood groups A (n = 2), B (n = 2) and O (n = 2) were sent to 29 institutions and anti-A/B Ab titer was measured by their customary methods. Isohemagglutinin assay in serial-doubling dilutions of serum using a test tube was widely used in all institutions. Inter-institutional difference between maximum and minimum value reached as much as 32-fold in immunoglobulin M (IgM) and 256-fold in IgG. As detailed protocol for assay seemed to be different between institutions, we attempted to standardize the protocol based on the result of a questionnaire survey. In 2004, a second survey was conducted in the same manner as the previous one, except participation involved 38 institutions and the measurement was performed in a uniform way using a provisional standard protocol. Analysis of the survey revealed that intra-institutional variation was reduced to below eightfold, except that several institutions showed a large difference from the mean titer and required some guidance. A periodical quality control survey is considered necessary to improve the accuracy of measurement. Anti-A/B Ab titer would provide useful information towards the prediction of rejection and the indication of treatments such as (double filtration) plasmapheresis, splenectomy, anti-CD20 monoclonal antibody and intravenous immunoglobulin. Standardization of the assay for anti-A/B Ab titer is essential for the fulfillment of a precise multicenter study, which will elucidate the significance of the measurement of anti-A/B Ab titer.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Blood group O recipients associated with early graft deterioration in living ABO-incompatible kidney transplantation.

              Blood group O individuals are known to have larger amounts of anti-ABO blood group (anti-A/B) IgG antibodies than A or B individuals. Therefore, in ABO-incompatible (ABOI) kidney transplantation (KTX), it is expected that blood group O recipients are more likely to suffer graft damage, because anti-A/B IgG antibodies are believed to be responsible for worse graft outcomes. This study assessed the graft outcomes between blood group O and non-O recipients in ABOI-KTX. A total of 164 consecutive recipients who underwent ABOI-KTX between 1990 and 2007 under three different immunosuppressive protocols were enrolled in this study. The study population was divided into two groups: (i) recipients with blood group O (n=87) and (ii) recipients with blood group A or B (non-O) (n=77). High anti-A/B IgG titers were predominant in the O group (P<0.001), whereas no significant difference was observed in the IgM titers. The overall graft survival rate did not differ between the two groups; however, the 6-month graft survival rate was significantly lower in the O group (86% vs. 97%, P=0.011). Among 14 recipients who suffered graft loss within 6 months after transplantation, 12 (86%) were O recipients. The cumulative incidence of acute antibody-mediated rejection was significantly higher in the O group (60 days, 31 vs. 14%, P=0.013). Our results may indicate that being a blood group O recipient is at great risk for experiencing early allograft deterioration, probably caused by anti-A/B IgG antibodies in ABOI-KTX.
                Bookmark

                Author and article information

                Journal
                Ann Lab Med
                Ann Lab Med
                ALM
                Annals of Laboratory Medicine
                The Korean Society for Laboratory Medicine
                2234-3806
                2234-3814
                May 2014
                08 April 2014
                : 34
                : 3
                : 223-229
                Affiliations
                [1 ]Department of Laboratory Medicine, Soonchunhyang University Hospital, Seoul, Korea.
                [2 ]Department of Laboratory Medicine, Kangwon National University School of Medicine, Chuncheon, Korea.
                Author notes
                Corresponding author: Jeong Won Shin. Department of Laboratory Medicine, Soonchunhyang University Hospital, 59 Daesagwan-ro, Yongsan-gu, Seoul 140-887, Korea. Tel: +82-2-709-9423, Fax: +82-2-709-9083, jwshin@ 123456schmc.ac.kr
                Article
                10.3343/alm.2014.34.3.223
                3999321
                24790910
                ec86fd04-b368-415f-af25-17502fd4809c
                © The Korean Society for Laboratory Medicine.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 09 September 2013
                : 22 October 2013
                : 24 February 2014
                Funding
                Funded by: Soonchunhyang University Research Fund
                Categories
                Original Article
                Transfusion Medicine

                Clinical chemistry
                abo antibody,titer,dithiothreitol,igg
                Clinical chemistry
                abo antibody, titer, dithiothreitol, igg

                Comments

                Comment on this article